Jiage Ding
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Oncology 12
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 7
- Immunology 12
- Immunotherapy and Immune Responses 9
- Immune Cell Function and Interaction 4
- Complement system in diseases 2
- Co-authors
- Qing Zhang (5 shared papers)Mengmeng Lü (5 shared papers)Huizhong Li (9 shared papers)Hongyan Liu (4 shared papers)Junnian Zheng (14 shared papers)Liantao Li (2 shared papers)Junnian Zheng (4 shared papers)Gang Wang (12 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (2 papers)International Immunopharmacology (2 papers)Cancers (2 papers)Oncology Reports (1 paper)Journal of Immunotherapy (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Jiage Ding
17 papers receiving 427 citations
Peers
Comparison fields: 5 of 48
- Oncology 290
- Immunology 219
- Health Informatics 3
- Hepatology 14
- Cancer Research 26
Countries citing papers authored by Jiage Ding
This map shows the geographic impact of Jiage Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiage Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiage Ding more than expected).
Fields of papers citing papers by Jiage Ding
This network shows the impact of papers produced by Jiage Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiage Ding. The network helps show where Jiage Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiage Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 131 | |
| 2 | 2019 | 88 | |
| 3 | Akt inhibition at the initial stage of CAR-T preparation enhances the CAR-positive expression rate, memory phenotype and in vivo efficacy. | 2019 | 41 |
| 4 | Lenvatinib promotes antitumor immunity by enhancing the tumor infiltration and activation of NK cells. | 2019 | 35 |
| 5 | 2018 | 28 | |
| 6 | 2022 | 15 | |
| 7 | 2021 | 15 | |
| 8 | 2023 | 14 | |
| 9 | 2021 | 13 | |
| 10 | 2022 | 12 | |
| 11 | 2021 | 11 | |
| 12 | 2022 | 8 | |
| 13 | 2023 | 6 | |
| 14 | 2023 | 5 | |
| 15 | 2024 | 5 | |
| 16 | 2025 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2024 | 0 |
About Jiage Ding
Jiage Ding is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 18 papers that have together received 430 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immune Cell Function and Interaction (4 papers), Complement system in diseases (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Oncology (290 citations), Immunology (219 citations), Health Informatics (3 citations), Hepatology (14 citations) and Cancer Research (26 citations). Jiage Ding has collaborated with scholars based in China, United States and India. Frequent co-authors include Qing Zhang, Mengmeng Lü, Huizhong Li, Hongyan Liu, Junnian Zheng, Liantao Li, Junnian Zheng, Gang Wang, Hailong Li and Dafei Chai. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, International Immunopharmacology, Cancers, Oncology Reports and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.